NYSE - Delayed Quote • USD
Concord Medical Services Holdings Limited (CCM)
At close: April 19 at 3:36 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 34.39M | 34.39M | 34.39M | 40.29M |
| Low Estimate | 34.39M | 34.39M | 34.39M | 40.29M |
| High Estimate | 34.39M | 34.39M | 34.39M | 40.29M |
| Year Ago Sales | 28.49M | 28.49M | 28.49M | 34.39M |
| Sales Growth (year/est) | 20.70% | 20.70% | 20.70% | 17.20% |
Earnings History
| CURRENCY IN USD | ||||
|---|---|---|---|---|
| EPS Est. | -- | -- | -- | -- |
| EPS Actual | -- | -- | -- | -- |
| Difference | -- | -- | -- | -- |
| Surprise % | -- | -- | -- | -- |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | -0.22 | -0.15 |
| 30 Days Ago | 0 | 0 | -0.22 | -0.15 |
| 60 Days Ago | 0 | 0 | -0.22 | -0.15 |
| 90 Days Ago | 0 | 0 | -0.22 | -0.15 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2021) | Next Qtr. (Jun 2021) | Current Year (2020) | Next Year (2021) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | CCM | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 1.60% |
| Next Qtr. | -- | -- | -- | 10.50% |
| Current Year | -- | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.30% |
| Next 5 Years (per annum) | 20.00% | -- | -- | 11.22% |
| Past 5 Years (per annum) | -5.13% | -- | -- | -- |
Research Analysis
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Upgrades & Downgrades
| Maintains | Morgan Stanley: Overweight | 11/23/2012 |
| Maintains | Morgan Stanley: Overweight | 7/6/2012 |
| Maintains | JP Morgan: Overweight | 3/22/2012 |